Biomarin Pharmaceutical Inc (BMRN) Insider Trading
- $1,316,196.75
- $342,139,664.94
- Nov. 12, 2024
- Jean Jacques Bienaime
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 12, 2024 | EVP | 5,278 | $66.37 | Sell | $350,300.86 | |
May 30, 2024 | CFO | 5,000 | $75.19 | Sell | $375,950.00 | |
May 28, 2024 | EVP | 40,850 | $74.51 | Sell | $3,043,733.50 | |
May 9, 2024 | Director | 20,000 | $81.62 | Sell | $1,632,400.00 | |
May 2, 2024 | EVP | 1,850 | $85.01 | Sell | $157,268.50 | |
April 12, 2024 | Director | 20,000 | $91.26 | Sell | $1,825,200.00 | |
April 10, 2024 | CAO | 2,286 | $90.00 | Sell | $205,740.00 | |
March 28, 2024 | EVP | 24,602 | $88.34 | Sell | $2,173,340.68 | |
March 5, 2024 | Director | 1,000 | $85.51 | Sell | $85,510.00 | |
March 5, 2024 | EVP | 4,000 | $87.07 | Sell | $348,280.00 | |
March 5, 2024 | Insider | 35,341 | $85.18 | Sell | $3,010,346.38 | |
Feb. 27, 2024 | Director | 1,000 | $90.35 | Sell | $90,350.00 | |
Feb. 9, 2024 | Director | 15,000 | $88.28 | Sell | $1,324,200.00 | |
Jan. 9, 2024 | Director | 10,000 | $98.19 | Sell | $981,900.00 | |
Dec. 21, 2023 | Director | 10,000 | $93.99 | Sell | $939,900.00 | |
Dec. 13, 2023 | EVP | 13,764 | $95.30 | Sell | $1,311,709.20 | |
Aug. 16, 2023 | EVP | 5,000 | $90.00 | Sell | $450,000.00 | |
Aug. 10, 2023 | Insider | 12,000 | $90.43 | Sell | $1,085,160.00 | |
Aug. 8, 2023 | EVP | 11,000 | $89.42 | Sell | $983,620.00 | |
Aug. 7, 2023 | CEO | 4,000 | $88.10 | Sell | $352,400.00 | |
May 10, 2023 | CEO | 30,000 | $94.85 | Sell | $2,845,500.00 | |
April 10, 2023 | CEO | 10,000 | $99.56 | Sell | $995,600.00 | |
April 6, 2023 | CEO | 10,000 | $96.13 | Sell | $961,300.00 | |
April 3, 2023 | Director | 8,500 | $97.09 | Sell | $825,265.00 | |
March 13, 2023 | CEO | 8,000 | $90.45 | Sell | $723,600.00 | |
March 10, 2023 | CEO | 15,000 | $92.28 | Sell | $1,384,200.00 | |
Feb. 13, 2023 | CEO | 6,000 | $109.15 | Sell | $654,900.00 | |
Feb. 10, 2023 | CEO | 15,000 | $110.11 | Sell | $1,651,650.00 | |
Jan. 25, 2023 | EVP | 49,000 | $115.70 | Sell | $5,669,300.00 | |
Jan. 17, 2023 | CEO | 10,000 | $111.55 | Sell | $1,115,500.00 | |
Jan. 13, 2023 | CEO | 10,000 | $112.25 | Sell | $1,122,500.00 | |
Jan. 13, 2023 | CFO | 2,500 | $114.50 | Sell | $286,250.00 | |
Dec. 13, 2022 | CEO | 1,000 | $106.89 | Sell | $106,890.00 | |
Dec. 13, 2022 | CFO | 2,500 | $107.50 | Sell | $268,750.00 | |
Dec. 2, 2022 | CEO | 1,500 | $103.98 | Sell | $155,970.00 | |
Dec. 2, 2022 | CFO | 7,001 | $104.50 | Sell | $731,604.50 | |
Nov. 23, 2022 | CFO | 5,379 | $98.73 | Sell | $531,068.67 | |
Nov. 2, 2022 | EVP | 3,000 | $86.12 | Sell | $258,360.00 | |
Oct. 31, 2022 | CEO | 1,500 | $86.55 | Sell | $129,825.00 | |
Oct. 31, 2022 | Director | 3,625 | $86.75 | Buy | $314,468.75 | |
Oct. 14, 2022 | CEO | 4,000 | $89.89 | Sell | $359,560.00 | |
Aug. 15, 2022 | CEO | 3,000 | $95.21 | Sell | $285,630.00 | |
Aug. 12, 2022 | CEO | 4,000 | $94.75 | Sell | $379,000.00 | |
Aug. 11, 2022 | EVP | 3,000 | $95.62 | Sell | $286,860.00 | |
Aug. 8, 2022 | EVP | 6,205 | $96.56 | Sell | $599,154.80 | |
July 8, 2022 | EVP | 7,398 | $90.00 | Sell | $665,820.00 | |
July 8, 2022 | EVP, Chief Legal Officer | 7,398 | $90.00 | Sell | $665,820.00 | |
July 8, 2022 | EVP, Chief Financial Officer | 7,337 | $89.50 | Sell | $656,661.50 | |
May 26, 2022 | EVP | 1,308 | $78.94 | Sell | $103,253.52 | |
May 5, 2022 | CEO | 10,000 | $84.14 | Sell | $841,400.00 |
Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.
The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere
The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.
Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.
David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.
The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.
The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.
The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.